(PBI) Pitney Bowes - Ratings and Ratios
Postage, Meters, Software, Shipping
PBI EPS (Earnings per Share)
PBI Revenue
Description: PBI Pitney Bowes
Pitney Bowes Inc (NYSE:PBI) is a US-based company operating in the Office Services & Supplies sub-industry. The companys stock has been exhibiting a range of support levels between $9.1 and $10.5, indicating potential areas of buying interest.
From a fundamental perspective, Pitney Bowes has a market capitalization of approximately $1.94 billion, with a price-to-earnings ratio of 14.06 and a forward P/E of 9.00. This suggests that the market expects earnings to grow in the future. The absence of Return on Equity (RoE) data may indicate that the company has negative or negligible equity, or that the data is not readily available.
Key economic drivers for Pitney Bowes include the demand for office services and supplies, as well as the overall health of the US economy. As a supplier of office equipment and services, the companys performance is likely tied to the level of business activity and spending on office infrastructure. Relevant KPIs to monitor include revenue growth, operating margins, and cash flow generation.
To further evaluate Pitney Bowes prospects, it would be essential to analyze its financial statements, focusing on metrics such as debt-to-equity ratio, interest coverage, and return on assets (RoA). Additionally, industry trends, competitive positioning, and managements strategic initiatives should be assessed to gauge the companys potential for long-term growth and profitability.
PBI Stock Overview
| Market Cap in USD | 1,967m |
| Sub-Industry | Office Services & Supplies |
| IPO / Inception | 1972-06-01 |
PBI Stock Ratings
| Growth Rating | 81.9% |
| Fundamental | 50.9% |
| Dividend Rating | 52.4% |
| Return 12m vs S&P 500 | 48.3% |
| Analyst Rating | 3.0 of 5 |
PBI Dividends
| Dividend Yield 12m | 2.56% |
| Yield on Cost 5y | 5.65% |
| Annual Growth 5y | 0.00% |
| Payout Consistency | 94.5% |
| Payout Ratio | 23.0% |
PBI Growth Ratios
| Growth Correlation 3m | 56.6% |
| Growth Correlation 12m | 91.6% |
| Growth Correlation 5y | 22.5% |
| CAGR 5y | 71.45% |
| CAGR/Max DD 3y | 1.83 |
| CAGR/Mean DD 3y | 7.61 |
| Sharpe Ratio 12m | 0.42 |
| Alpha | 0.27 |
| Beta | 0.015 |
| Volatility | 49.33% |
| Current Volume | 2880.4k |
| Average Volume 20d | 2616.8k |
| Stop Loss | 10.9 (-4.2%) |
| Signal | 0.23 |
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income (-110.4m TTM) > 0 and > 6% of Revenue (6% = 118.3m TTM) |
| FCFTA 0.06 (>2.0%) and ΔFCFTA 2.92pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -18.41% (prev -2.44%; Δ -15.97pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.08 (>3.0%) and CFO 243.6m > Net Income -110.4m (YES >=105%, WARN >=100%) |
| Net Debt (1.74b) to EBITDA (187.6m) ratio: 9.27 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.76 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (181.0m) change vs 12m ago 1.29% (target <= -2.0% for YES) |
| Gross Margin 53.57% (prev 36.12%; Δ 17.45pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 53.87% (prev 72.82%; Δ -18.95pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 0.94 (EBITDA TTM 187.6m / Interest Expense TTM 103.7m) >= 6 (WARN >= 3) |
Altman Z'' 2.74
| (A) -0.11 = (Total Current Assets 1.13b - Total Current Liabilities 1.49b) / Total Assets 3.24b |
| (B) 0.82 = Retained Earnings (Balance) 2.67b / Total Assets 3.24b |
| warn (B) unusual magnitude: 0.82 — check mapping/units |
| (C) 0.03 = EBIT TTM 97.7m / Avg Total Assets 3.66b |
| (D) 0.58 = Book Value of Equity 2.18b / Total Liabilities 3.78b |
| Total Rating: 2.74 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 50.94
| 1. Piotroski 4.0pt = -1.0 |
| 2. FCF Yield 5.05% = 2.52 |
| 3. FCF Margin 9.23% = 2.31 |
| 4. Debt/Equity data missing |
| 5. Debt/Ebitda 10.25 = -2.50 |
| 6. ROIC - WACC (= 1.70)% = 2.13 |
| 7. RoE data missing |
| 8. Rev. Trend -85.19% = -6.39 |
| 9. EPS Trend 77.47% = 3.87 |
What is the price of PBI shares?
Over the past week, the price has changed by -3.07%, over one month by +2.43%, over three months by +8.85% and over the past year by +76.11%.
Is Pitney Bowes a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of PBI is around 13.77 USD . This means that PBI is currently undervalued and has a potential upside of +21% (Margin of Safety).
Is PBI a buy, sell or hold?
- Strong Buy: 0
- Buy: 0
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the PBI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 17 | 49.4% |
| Analysts Target Price | 17 | 49.4% |
| ValueRay Target Price | 14.7 | 28.9% |
Last update: 2025-09-12 04:42
PBI Fundamental Data Overview
CCE Cash And Equivalents = 285.2m USD (last quarter)
P/E Trailing = 14.2875
P/E Forward = 7.2464
P/S = 0.9982
P/B = 9.5693
P/EG = 0.6048
Beta = 1.275
Revenue TTM = 1.97b USD
EBIT TTM = 97.7m USD
EBITDA TTM = 187.6m USD
Long Term Debt = 1.88b USD (from longTermDebt, last quarter)
Short Term Debt = 42.4m USD (from shortTermDebt, last quarter)
Debt = 1.92b USD (Calculated: Short Term 42.4m + Long Term 1.88b)
Net Debt = 1.74b USD (from netDebt column, last quarter)
Enterprise Value = 3.61b USD (1.97b + Debt 1.92b - CCE 285.2m)
Interest Coverage Ratio = 0.94 (Ebit TTM 97.7m / Interest Expense TTM 103.7m)
FCF Yield = 5.05% (FCF TTM 182.0m / Enterprise Value 3.61b)
FCF Margin = 9.23% (FCF TTM 182.0m / Revenue TTM 1.97b)
Net Margin = -5.60% (Net Income TTM -110.4m / Revenue TTM 1.97b)
Gross Margin = 53.57% ((Revenue TTM 1.97b - Cost of Revenue TTM 915.2m) / Revenue TTM)
Tobins Q-Ratio = 1.66 (Enterprise Value 3.61b / Book Value Of Equity 2.18b)
Interest Expense / Debt = 1.30% (Interest Expense 24.9m / Debt 1.92b)
Taxrate = 23.67% (9.30m / 39.3m)
NOPAT = 74.5m (EBIT 97.7m * (1 - 23.67%))
Current Ratio = 0.76 (Total Current Assets 1.13b / Total Current Liabilities 1.49b)
Debt / EBITDA = 10.25 (Net Debt 1.74b / EBITDA 187.6m)
Debt / FCF = 10.57 (Debt 1.92b / FCF TTM 182.0m)
Total Stockholder Equity = -542.5m (last 4 quarters mean)
RoA = -3.41% (Net Income -110.4m, Total Assets 3.24b )
RoE = unknown (Net Income TTM -110.4m / Total Stockholder Equity -542.5m)
RoCE = 7.29% (Ebit 97.7m / (Equity -542.5m + L.T.Debt 1.88b))
RoIC = 5.26% (NOPAT 74.5m / Invested Capital 1.42b)
WACC = 3.56% (E(1.97b)/V(3.89b) * Re(6.07%)) + (D(1.92b)/V(3.89b) * Rd(1.30%) * (1-Tc(0.24)))
Shares Correlation 3-Years: 56.49 | Cagr: 0.21%
Discount Rate = 6.07% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
[DCF Debug] Terminal Value 70.46% ; FCFE base≈153.3m ; Y1≈100.6m ; Y5≈46.0m
Fair Price DCF = 5.26 (DCF Value 904.7m / Shares Outstanding 172.1m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 77.47 | EPS CAGR: 119.7% | SUE: -0.15 | # QB: 0
Revenue Correlation: -85.19 | Revenue CAGR: -19.23% | SUE: N/A | # QB: None
Additional Sources for PBI Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle